Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,821 to 1,840 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unexpected Actors in Inflammatory Bowel Disease Revealed by Machine Learning from Whole-Blood Transcriptomic Data. | Genes (Basel) | 2022 | 36140740 | PubTator, text mining | PubMed |
| Crosstalk of Oxidative Phosphorylation-Related Subtypes, Establishment of a Prognostic Signature and Immune Infiltration Characteristics in Colorectal Adenocarcinoma. | Cancers (Basel) | 2022 | 36139663 | PubTator, text mining | PubMed |
| Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis. | Cancers (Basel) | 2022 | 36139662 | PubTator, text mining | PubMed |
| Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential. | Biomolecules | 2022 | 36139062 | PubTator, text mining | PubMed |
| RNA modifications: importance in immune cell biology and related diseases. | Signal Transduct Target Ther | 2022 | 36138023 | PubTator, text mining | PubMed |
| Unveiling the m6A Methylation Regulator Links between Prostate Cancer and Periodontitis by Transcriptomic Analysis. | Dis Markers | 2022 | 36133437 | PubTator, text mining | PubMed |
| N6-Methyladenosine RNA Modification Landscape in the Occurrence and Recurrence of Nasopharyngeal Carcinoma. | World J Oncol | 2022 | 36128587 | PubTator, text mining | PubMed |
| Prognostic value of m6A regulators and the nomogram construction in glioma patients. | Medicine (Baltimore) | 2022 | 36123877 | PubTator, text mining | PubMed |
| New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC. | Front Pharmacol | 2022 | 36120320 | PubTator, text mining | PubMed |
| The role of RNA modification in hepatocellular carcinoma. | Front Pharmacol | 2022 | 36120301 | PubTator, text mining | PubMed |
| m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients. | Front Oncol | 2022 | 36119534 | PubTator, text mining | PubMed |
| Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma. | Front Genet | 2022 | 36118882 | PubTator, text mining | PubMed |
| Novel amino acid metabolism-related gene signature to predict prognosis in clear cell renal cell carcinoma. | Front Genet | 2022 | 36118874 | PubTator, text mining | PubMed |
| Peroxidase is a novel potential marker in glioblastoma through bioinformatics method and experimental validation. | Front Genet | 2022 | 36118855 | PubTator, text mining | PubMed |
| Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss. | Front Genet | 2022 | 36118846 | PubTator, text mining | PubMed |
| MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia. | Comput Math Methods Med | 2022 | 36118827 | PubTator, text mining | PubMed |
| Implications of m6A methylation and microbiota interaction in non-small cell lung cancer: From basics to therapeutics. | Front Cell Infect Microbiol | 2022 | 36118041 | PubTator, text mining | PubMed |
| Adenosine N6-methylation upregulates the expression of human CYP2B6 by altering the chromatin status. | Biochem Pharmacol | 2022 | 36113565 | PubTator, text mining | PubMed |
| Prognostic model based on m6A-associated lncRNAs in esophageal cancer. | Front Endocrinol (Lausanne) | 2022 | 36111294 | PubTator, text mining | PubMed |
| The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer. | J Oncol | 2022 | 36111241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=92